Dmitry I. Gabrilovich
AstraZeneca (Netherlands) · 662 works · 82,919 citations · h-index 118
Top works
- Myeloid-derived suppressor cells as regulators of the immune system
- Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
- Coordinated regulation of myeloid cells by tumours
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer
- Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
- Immunosuppressive Strategies that are Mediated by Tumor Cells
- Vascular Endothelial Growth Factor Inhibits the Development of Dendritic Cells and Dramatically Affects the Differentiation of Multiple Hematopoietic Lineages In Vivo
- Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
- Mechanisms and functional significance of tumour-induced dendritic-cell defects
- Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
- Antigen-Specific Inhibition of CD8+ T Cell Response by Immature Myeloid Cells in Cancer Is Mediated by Reactive Oxygen Species
- Mechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells
- Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer
- Clinical significance of defective dendritic cell differentiation in cancer.
- Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
- The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
- Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function.
- The Terminology Issue for Myeloid-Derived Suppressor Cells
- HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment